| Fosamprenavir |
EU/1/04/ 282/001 |
TELZIR, Film coated tablet, 700, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Wellcome Operations, United Kingdom |
523.83 |
104.77 |
628.6 |
4% |
10 |
533.83 |
106.77 |
640.6 |
16% |
25 |
558.83 |
111.77 |
670.6 |
|
НСР-6086/23.04.2015. |
08.05.2015 |
08.05.2015 |
Неактивен |
3825 |
| Fosamprenavir |
EU/1/04/282/001 |
TELZIR, Film coated tablet, 700, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Wellcome Operations, United Kingdom |
532.57 |
106.51 |
639.08 |
4% |
10 |
542.57 |
108.51 |
651.08 |
16% |
25 |
567.57 |
113.51 |
681.08 |
|
НСР-4322/05.08.2014 |
20.08.2014 |
20.08.2014 |
Неактивен |
3825 |
| Fosamprenavir |
EU/1/04/282/001 |
TELZIR, Film coated tablet, 700, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Wellcome Operations, United Kingdom |
541.65 |
108.33 |
649.98 |
4% |
10 |
551.65 |
110.33 |
661.98 |
16% |
25 |
576.65 |
115.33 |
691.98 |
|
НСР-1912/27.11.2013 |
17.12.2013 |
17.12.2013 |
Неактивен |
3825 |
| Fosamprenavir |
EU/1/04/282/001 |
TELZIR, Film coated tablet, 700, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Wellcome Operations, United Kingdom |
549.59 |
109.92 |
659.51 |
4% |
10 |
559.59 |
111.92 |
671.51 |
16% |
25 |
584.59 |
116.92 |
701.51 |
|
КЦРР-2459/27.02.2013 |
26.03.2013 |
26.03.2013 |
Неактивен |
3825 |
| Fosamprenavir |
Директива 2001/83/EO от 06 ноември 2001 |
TELZIR, Film coated tablet, 700, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Wellcome Operations, United Kingdom |
619.61 |
123.92 |
743.53 |
4% |
10 |
629.61 |
125.92 |
755.53 |
16% |
25 |
654.61 |
130.92 |
785.53 |
КЦ-1780/01.10.2010 за промяна на обстоятелства |
КЦ-262/27.10.2008 |
18.11.2008 |
18.11.2008 |
Неактивен |
3825 |
| Temozolomide |
EU/1/98/ 096/015 |
Temodal, Capsule, hard, 100, mg, Pack: 5 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP Labo N.V., Belgium |
115.26 |
23.05 |
138.31 |
4% |
4.61 |
119.87 |
23.97 |
143.84 |
16% |
18.44 |
138.31 |
27.66 |
165.97 |
|
НСР-7715/17.12.2015 |
02.01.2016 |
02.01.2016 |
Активен |
3029 |
| Temozolomide |
EU/1/98/ 096/015 |
Temodal, Capsule, hard, 100, mg, Pack: 5 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP Labo N.V., Belgium |
220.27 |
44.05 |
264.32 |
4% |
8.81 |
229.08 |
45.82 |
274.9 |
16% |
25 |
254.08 |
50.82 |
304.9 |
|
НСР-3945/30.06.2014 |
15.07.2014 |
15.07.2014 |
Неактивен |
3029 |
| Temozolomide |
EU/1/98/096/015 |
Temodal, Capsule, hard, 20, mg, Pack: 5 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP Labo N.V., Belgium |
256.78 |
51.36 |
308.14 |
4% |
10 |
266.78 |
53.36 |
320.14 |
16% |
25 |
291.78 |
58.36 |
350.14 |
|
НСР-1339/07.10.2013 |
23.10.2013 |
23.10.2013 |
Неактивен |
1757 |
| Temozolomide |
EU/1/98/096/003 |
Temodal, Capsule, hard, 20, mg, Pack: 5 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP Labo N.V. - Belgium |
316.32 |
63.26 |
379.58 |
4% |
10 |
326.32 |
65.26 |
391.58 |
16% |
25 |
351.32 |
70.26 |
421.58 |
Цената се заличава с решение НСР-3581/23.05.2014 |
КЦРР-2507/06.03.2013 |
02.04.2013 |
02.04.2013 |
Заличен |
1757 |
| Temozolomide |
EU/1/98/096/003 |
Temodal, Capsule, hard, 100, mg, Pack: 5 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP Labo N.V. - Belgium |
70.14 |
14.03 |
84.17 |
4% |
2.81 |
72.95 |
14.59 |
87.54 |
16% |
11.22 |
84.17 |
16.83 |
101 |
Цената се заличава с решение НСР-2581/24.01.2014 |
КЦРР-2506/06.03.2013 |
02.04.2013 |
02.04.2013 |
Заличен |
1756 |
| Temozolomide |
EU/1/98/096/015 |
Temodal, Capsule, hard, 20, mg, Pack: 5 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP Labo N.V., Belgium |
316.32 |
63.26 |
379.58 |
4% |
10 |
326.32 |
65.26 |
391.58 |
16% |
25 |
351.32 |
70.26 |
421.58 |
|
КЦРР-1888/15.12.2012 г |
22.01.2013 |
22.01.2013 |
Неактивен |
1757 |
| Temozolomide |
EU/1/98/096/013 |
Temodal, Capsule, hard, 20, mg, Pack: 5 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP Labo N.V., Belgium |
70.14 |
14.03 |
84.17 |
4% |
2.81 |
72.95 |
14.59 |
87.54 |
16% |
11.22 |
84.17 |
16.83 |
101 |
Цената се заличава с решение НСР-2581/24.01.2014 |
КЦРР-1574/05.11.2012 |
06.12.2012 |
06.12.2012 |
Заличен |
1450 |
| Temozolomide |
EU/1/98/096/003 |
Temodal, Capsule, hard, 100, mg, Pack: 5 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP Labo N.V. - Belgium |
141.99 |
28.4 |
170.39 |
4% |
5.68 |
147.67 |
29.53 |
177.2 |
16% |
22.72 |
170.39 |
34.08 |
204.47 |
КЦPP-930/04.07.2012 за промяна на обстоятелства |
КЦ-331/28.11.2008 |
25.12.2008 |
25.12.2008 |
Неактивен |
1756 |
| Temozolomide |
EU/1/98/096/003 |
Temodal, Capsule, hard, 20, mg, Pack: 5 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP Labo N.V. - Belgium |
696.33 |
139.27 |
835.6 |
4% |
10 |
706.33 |
141.27 |
847.6 |
16% |
25 |
731.33 |
146.27 |
877.6 |
КЦPP-930/04.07.2012 за промяна на обстоятелства |
КЦ-331/28.11.2008 |
25.12.2008 |
25.12.2008 |
Неактивен |
1757 |
| Temozolomide |
EU/1/10/615/009 |
Temozolomide Accord, capsule, hard (in bottles), 100, mg, Pack: 5 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство |
350.48 |
70.1 |
420.58 |
4% |
10 |
360.48 |
72.1 |
432.58 |
16% |
25 |
385.48 |
77.1 |
462.58 |
|
НСР-8531/16.03.2016 |
31.03.2016 |
31.03.2016 |
Активен |
4195 |
| Temozolomide |
EU/1/10/615/005 |
TEMOZOLOMIDE HOSPIRA, Capsule, hard, 20, mg, Pack: 5 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK Ltd Queensway, Royal Leamington Spa Warwickshire Великобритания |
70 |
14 |
84 |
6% |
4.2 |
74.2 |
14.84 |
89.04 |
18% |
12.6 |
86.8 |
17.36 |
104.16 |
цената е заличена с решение КЦРР-1134/02.08.2012 |
КЦ-2902/10.10.2011 |
24.10.2011 |
24.10.2011 |
Заличен |
1127 |
| Temozolomide |
EU/1/10/615/009 |
TEMOZOLOMIDE HOSPIRA, Capsule, hard, 100, mg, Pack: 5 |
Hospira UK Ltd., Обединено Кралство |
Hospira UK Ltd Queensway, Royal Leamington Spa Warwickshire Великобритания |
350 |
70 |
420 |
6% |
15 |
365 |
73 |
438 |
18% |
30 |
395 |
79 |
474 |
цената е заличена с решение КЦРР-1134/02.08.2012 |
КЦ-2902/10.10.2011 |
24.10.2011 |
24.10.2011 |
Заличен |
1126 |
| Temozolomide |
EU/1/10/617/010 |
Temozolomide Sandoz, Capsule, hard, 100, mg, Pack: 20 |
Sandoz GmbH, Австрия |
Salutas Pharma GmbH, Otto-von-Guericke Allee, D-39179, Barleben, Germany; Lek Pharmaceuricals d.d. Veroskova 57, 1526 Ljubljana, Slovenia |
1401.94 |
280.39 |
1682.33 |
4% |
10 |
1411.94 |
282.39 |
1694.33 |
16% |
25 |
1436.94 |
287.39 |
1724.33 |
промяна на обстоятелства НСР-8273/26.02.2016. |
НСР-5549/29.01.2015 |
12.02.2015 |
12.02.2015 |
Активен |
3559 |
| Temozolomide |
EU/1/10/617/010 |
Temozolomide Sandoz, Capsule, hard, 100, mg, Pack: 20 |
Sandoz Pharmaceuticals GmbH, Германия |
Salutas Pharma GmbH, Otto-von-Guericke Allee, D-39179, Barleben, Germany; Lek Pharmaceuricals d.d. Veroskova 57, 1526 Ljubljana, Slovenia |
1402.7 |
280.54 |
1683.24 |
4% |
10 |
1412.7 |
282.54 |
1695.24 |
16% |
25 |
1437.7 |
287.54 |
1725.24 |
|
КЦРР-1754/04.12.2012 г |
20.12.2012 |
20.12.2012 |
Неактивен |
3559 |
| Temozolomide |
EU/1/09/606/005 |
Temozolomide Teva, Capsule, hard, 100, mg, Pack: 5 |
Teva Pharma B.V., Нидерландия |
NerPharMa S.r.l Viale Pasteur, 10, 20014 Nerviano (MI) Italy; Pharmachemie B.V. Swensweg 5, 2031 GA Haarlem, The Netherlands; TEVA Sante SA, Rue Bellocier, 89107 Sens, France; Haupt Pharma Amareg GmbH, Donaustaufer Strabe 378, 93055, Regensburg, Germany; Teva Operations Poland Sp.z.o.o., Krakow, Poland |
115.26 |
23.05 |
138.31 |
4% |
4.61 |
119.87 |
23.97 |
143.84 |
16% |
18.44 |
138.31 |
27.66 |
165.97 |
корекц. НСР-7729/17.12.2015 |
НСР-7309/29.10.2015; НСР-9067/21.04.2016 |
02.06.2016 |
02.06.2016 |
Заличен |
3043 |
| Temozolomide |
EU/1/09/606/005 |
Temozolomide Teva, Capsule, hard, 100, mg, Pack: 5 |
Teva Pharma B.V., Нидерландия |
NerPharMa S.r.l Viale Pasteur, 10, 20014 Nerviano (MI) Italy; Pharmachemie B.V. Swensweg 5, 2031 GA Haarlem, The Netherlands; TEVA Sante SA, Rue Bellocier, 89107 Sens, France; Haupt Pharma Amareg GmbH, Donaustaufer Strabe 378, 93055, Regensburg, Germany; Teva Operations Poland Sp.z.o.o., Krakow, Poland |
115.26 |
23.05 |
138.31 |
4% |
4.61 |
119.87 |
23.97 |
143.84 |
16% |
18.44 |
138.31 |
27.66 |
165.97 |
корекц. НСР-7729/17.12.2015 |
НСР-7309/29.10.2015 |
14.11.2015 |
14.11.2015 |
Неактивен |
3043 |
| Temozolomide |
EU/1/09/606/005 |
Temozolomide Teva, Capsule, hard, 100, mg, Pack: 5 |
Teva Pharma B.V., Нидерландия |
NerPharMa S.r.l Viale Pasteur, 10, 20014 Nerviano (MI) Italy; Pharmachemie B.V. Swensweg 5, 2031 GA Haarlem, The Netherlannds; TEVA Sante SA, Rue Bellocier, 89107 Sens, France; Haupt Pharma Amareg GmbH, Donaustaufer Strabe 378, 93055, Regensburg, Germany; Teva Operations Poland Sp.z.o.o., Krakow, Poland |
166.91 |
33.38 |
200.29 |
4% |
6.68 |
173.59 |
34.72 |
208.31 |
16% |
25 |
198.59 |
39.72 |
238.31 |
промяна на обстоятелства НСР-7102/15.09.2015 |
НСР-4156/23.07.2014 |
07.08.2014 |
07.08.2014 |
Неактивен |
3043 |
| Temozolomide |
EU/1/09/606/003 |
Temozolomide Teva, Capsule, hard, 20, mg, Pack: 5 |
Teva Pharma B.V., Нидерландия |
NerPharMa S.r.l Viale Pasteur, 10, 20014 Nerviano (MI) Italy; Pharmachemie B.V. Swensweg 5, 2031 GA Haarlem, The Netherlannds; TEVA Sante SA, Rue Bellocier, 89107 Sens, France; Haupt Pharma Amareg GmbH, Donaustaufer Strabe 378, 93055, Regensburg, Germany |
33.8 |
6.76 |
40.56 |
4% |
1.35 |
35.15 |
7.03 |
42.18 |
16% |
5.41 |
40.56 |
8.11 |
48.67 |
Цената се заличава с решение НСР-3712/06.06.2014 ( в сила от 23.06.2014) |
НСР-1522/25.10.2013 |
13.11.2013 |
13.11.2013 |
Заличен |
2219 |
| Temozolomide |
EU/1/09/606/005 |
Temozolomide Teva, Capsule, hard, 100, mg, Pack: 5 |
Teva Pharma B.V., Нидерландия |
NerPharMa S.r.l Viale Pasteur, 10, 20014 Nerviano (MI) Italy; Pharmachemie B.V. Swensweg 5, 2031 GA Haarlem, The Netherlannds; TEVA Sante SA, Rue Bellocier, 89107 Sens, France; Haupt Pharma Amareg GmbH, Donaustaufer Strabe 378, 93055, Regensburg, Germany |
168.96 |
33.79 |
202.75 |
4% |
6.76 |
175.72 |
35.14 |
210.86 |
16% |
25 |
200.72 |
40.14 |
240.86 |
|
НСР-1522/25.10.2013 |
13.11.2013 |
13.11.2013 |
Неактивен |
3043 |
| Temozolomide |
EU/1/09/606/003 |
Temozolomide Teva, Capsule, hard, 20, mg, Pack: 5 |
Teva Pharma B.V., Нидерландия |
NerPharMa S.r.l Viale Pasteur, 10, 20014 Nerviano (MI) Italy; Pharmachemie B.V. Swensweg 5, 2031 GA Haarlem, The Netherlannds; TEVA Sante SA, Rue Bellocier, 89107 Sens, France; Haupt Pharma Amareg GmbH, Donaustaufer Strabe 378, 93055, Regensburg, Germany |
48.72 |
9.74 |
58.46 |
4% |
1.95 |
50.67 |
10.13 |
60.8 |
16% |
7.8 |
58.47 |
11.69 |
70.16 |
|
КЦРР-1933/17.12.2012 г |
03.01.2013 |
03.01.2013 |
Неактивен |
2219 |